Deepinder Goyal says his longevity venture has been investigating a new explanation for why humans age. Posting on X, he called it a “crazy insight” that has been hiding in plain sight, hinting at findings that could challenge existing understandings of aging. The entrepreneur didn’t share details yet, leaving many questions about the science behind the claim.
Retatrutide, an investigational weight-loss drug, is drawing global attention after early clinical results showed substantial weight reduction. What makes it stand out is its “triple-action” approach, targeting three hormone receptors involved in metabolism. Researchers are also exploring whether it could support broader longevity goals, potentially offering new options for obesity and related diabetes.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
